09/03/2024 4:10 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:11 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:14 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024 6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2024 5:07 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024 3:26 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024 3:08 PM | Ascendis Pharma A/S (Filer)
| Form SD Specialized Disclosure Report | |
|
05/14/2024 1:37 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024 8:16 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024 10:31 AM | Ascendis Pharma A/S (Subject) Bodenhoff Mads (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 8:39 PM | Ascendis Pharma A/S (Subject) Fairey William (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 8:47 AM | Ascendis Pharma A/S (Subject) Cha Albert (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 7:04 AM | Ascendis Pharma A/S (Subject) SPROGOE KENNETT (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 7:14 AM | Ascendis Pharma A/S (Subject) Morrison Lisa (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:52 AM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:37 AM | Ascendis Pharma A/S (Subject) JENSEN FLEMMING STEEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 1:54 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 2:07 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 2:17 PM | Ascendis Pharma A/S (Subject) RASMUSSEN PETER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 1:36 PM | Ascendis Pharma A/S (Subject) SMITH SCOTT THOMAS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 1:24 PM | Ascendis Pharma A/S (Subject) SINGEL STINA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 10:00 AM | Ascendis Pharma A/S (Subject) HOLTUG LARS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 4:13 PM | Ascendis Pharma A/S (Subject) Morrison Lisa (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 3:21 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024 5:17 PM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024 4:45 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 2:17 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 4:14 PM | Ascendis Pharma A/S (Subject) Volck Birgitte (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 4:15 PM | Ascendis Pharma A/S (Subject) JENSEN FLEMMING STEEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 4:16 PM | Ascendis Pharma A/S (Subject) SMITH SCOTT THOMAS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 10:40 AM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 8:17 AM | Ascendis Pharma A/S (Subject) Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
02/13/2024 10:57 AM | Ascendis Pharma A/S (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/12/2024 5:12 AM | Artisan Partners Limited Partnership (Filed by) Ascendis Pharma A/S (Subject)
| Form SC 13G/A | |
02/09/2024 1:17 PM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 7:35 AM | Ascendis Pharma A/S (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
02/07/2024 3:15 PM | Ascendis Pharma A/S (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
02/02/2024 12:18 PM | Ascendis Pharma A/S (Subject) WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SC 13G/A | |
01/29/2024 7:36 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 5:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 5:08 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
War on Elon Escalates… (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9244&Placement=NativeDisplay&Source=NativeDisplay) One company holds a near-total monopoly on it. |
01/02/2024 5:08 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023 7:30 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023 7:32 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/07/2023 1:53 PM | Ascendis Pharma A/S (Subject) Volck Birgitte (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023 3:20 PM | Ascendis Pharma A/S (Subject) RASMUSSEN PETER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 5:04 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2023 7:30 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2023 3:06 PM | Ascendis Pharma A/S (Subject) Volck Birgitte (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2023 3:26 PM | Ascendis Pharma A/S (Subject) SMITH SCOTT THOMAS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023 2:47 PM | Ascendis Pharma A/S (Subject) Volck Birgitte (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023 3:10 PM | Ascendis Pharma A/S (Subject) SPROGOE KENNETT (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/15/2023 3:34 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/15/2023 3:19 PM | Ascendis Pharma A/S (Subject) JENSEN FLEMMING STEEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023 11:42 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2023 2:12 PM | Ascendis Pharma A/S (Subject) RASMUSSEN PETER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 8:15 AM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144/A | |
09/08/2023 7:00 PM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:40 PM | Ascendis Pharma A/S (Subject) Cha Albert (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |